Renforcer la participation politique : une approche évaluative du projet du Bureau lausannois pour les immigrés "Votre Ville, Votre Vie, Votre Voix"

Ce mémoire de recherche a pour thématique la participation politique, dans son acception large. Celle-ci est abordée sous un angle novateur, celui des politiques publiques. Les objectifs sont, d'une part, de déterminer les mécanismes mis en place pour renforcer la participation politique et, d'autre part, d'en évaluer les impacts. L'étude consiste en une étude de cas du projet « Votre Ville, Votre Vie, Votre Voix » développé par le Bureau lausannois pour les immigrés. Plus précisément, deux sortes d'activités menées entre mars et juin 2014 dans le cadre de ce projet ont été sélectionnées pour l'évaluation : une séance d'information sur les droits politiques et des visites d'institutions politiques. Pour ce faire, une dizaine de participants à ces activités ont été interviewés. Les résultats de l'étude mettent en évidence des impacts marqués sur les facteurs de la participation politique liés aux affects ou aux opinions et des impacts moins nets sur la compétence politique et sur les différentes composantes du comportement politique. Ces différents effets ressortent enfin plus clairement chez les interviewés ayant participé aux visites qu'à la séance.

Approche preventive des pathologies démentietlles [Preventive approaches to dementia].

Prevalence and incidence of dementia increase with demographic aging. Benefits of current antidementia drugs are modest, both in cognitive and functional domains. Therefore, interest is growing to evaluate the effects of interventions aiming at preventing cognitive decline and, ideally, dementia onset. Cognitive training and physical activity seem promising. This paper describes recent studies that assessed the benefits of preventive strategies in the domain of dementia, especially in Alzheimer's disease.

Des métiers pour aider : apport de l'approche cognitivo-comportementale et de ses outils.

Comment aider professionnellement tout en respectant l'autre, sans être intrusif, sans faire à la place de l'autre? Il ne suffit pas de maîtriser son art comme par exemple celui du soutien psychosocial ou neuropsychologique, il est aussi essentiel de maîtriser l'art de l'intervention aidante. Par exemple, aider l'autre consiste souvent à permettre à l'autre d'apprendre quelque chose de nouveau pour qu'il se sente mieux, que ce soit au plan physique, affectif ou cognitif. Comment favoriser chez son client l'envie d'apprendre et de changer? Dans cet ouvrage, nous montrons que le paradigme cognitivo-comportemental est intéressant pour développer cet art de l'intervention aidante. En effet, cette approche est pour l'essentiel construite autour des notions d'apprentissage et d'adaptation: en particulier l'apprentissage de nouvelles façons d'agir, de penser et de se représenter le monde (Ladouceur et al. 2001; Fontaine et al. 1984; Cottraux, 2004). Nous montrons comment les outils utilisés dans l'approche cognitivo-comportementale peuvent aisément s'adapter dans des cadres professionnels fondés sur une relation d'aide mais autres que la psychothérapie. Des exemples concrets documentent comment utiliser ces outils.

Test result-based sampling: an efficient design for estimating the accuracy of patient safety indicators.

OBJECTIVE: Accuracy studies of Patient Safety Indicators (PSIs) are critical but limited by the large samples required due to low occurrence of most events. We tested a sampling design based on test results (verification-biased sampling [VBS]) that minimizes the number of subjects to be verified. METHODS: We considered 3 real PSIs, whose rates were calculated using 3 years of discharge data from a university hospital and a hypothetical screen of very rare events. Sample size estimates, based on the expected sensitivity and precision, were compared across 4 study designs: random and VBS, with and without constraints on the size of the population to be screened. RESULTS: Over sensitivities ranging from 0.3 to 0.7 and PSI prevalence levels ranging from 0.02 to 0.2, the optimal VBS strategy makes it possible to reduce sample size by up to 60% in comparison with simple random sampling. For PSI prevalence levels below 1%, the minimal sample size required was still over 5000. CONCLUSIONS: Verification-biased sampling permits substantial savings in the required sample size for PSI validation studies. However, sample sizes still need to be very large for many of the rarer PSIs.

Design, conduct, and analyses of Breast International Group (BIG) 1-98: a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer.

BACKGROUND: Aromatase inhibitors provide superior disease control when compared with tamoxifen as adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer. PURPOSE: To present the design, history, and analytic challenges of the Breast International Group (BIG) 1-98 trial: an international, multicenter, randomized, double-blind, phase-III study comparing the aromatase inhibitor letrozole with tamoxifen in this clinical setting. METHODS: From 1998-2003, BIG 1-98 enrolled 8028 women to receive monotherapy with either tamoxifen or letrozole for 5 years, or sequential therapy of 2 years of one agent followed by 3 years of the other. Randomization to one of four treatment groups permitted two complementary analyses to be conducted several years apart. The first, reported in 2005, provided a head-to-head comparison of letrozole versus tamoxifen. Statistical power was increased by an enriched design, which included patients who were assigned sequential treatments until the time of the treatment switch. The second, reported in late 2008, used a conditional landmark approach to test the hypothesis that switching endocrine agents at approximately 2 years from randomization for patients who are disease-free is superior to continuing with the original agent. RESULTS: The 2005 analysis showed the superiority of letrozole compared with tamoxifen. The patients who were assigned tamoxifen alone were unblinded and offered the opportunity to switch to letrozole. Results from other trials increased the clinical relevance about whether or not to start treatment with letrozole or tamoxifen, and analysis plans were expanded to evaluate sequential versus single-agent strategies from randomization. LIMITATIONS: Due to the unblinding of patients assigned tamoxifen alone, analysis of updated data will require ascertainment of the influence of selective crossover from tamoxifen to letrozole. CONCLUSIONS: BIG 1-98 is an example of an enriched design, involving complementary analyses addressing different questions several years apart, and subject to evolving analytic plans influenced by new data that emerge over time.

Approche diagnostique de l'hyponatrémie [Hyponatremia: diagnostic approach].

Hyponatremia is the most common electrolyte disorder in hospitalized patients and may be associated with non negligible morbidity and mortality. Here we summerize its diagnostic approach based on the physiopathology. Assessment of volume status, measurement of plasma and urinary osmolality remain key steps in the management of this electrolyte disorder.

L'Ouverture émotionnelle: une nouvelle approche du vécu et du traitement émotionnels

L'Ouverture émotionnelle (OE) est une nouvelle approche théorique et pratique qui s'inscrit dans le domaine du vécu et du traitement des émotions. Le modèle de l'OE se base sur l'évaluation et l'analyse de cinq dimensions élémentaires ancrées dans les théories modernes des émotions (la représentation cognitive des états émotionnels, la perception des indicateurs émotionnels corporels internes et externes, l'expression et la communication des émotions et la régulation des émotions). Ces éléments permettent de caractériser l'affectivité des personnes et de réfléchir ainsi à une prise en charge la plus adaptée possible. Cet ouvrage se veut un véritable guide de la pratique de l'Ouverture émotionnelle tant pour les professionnels de la santé mentale (psychologues, psychothérapeutes...) que pour les étudiants en psychologie. Après une présentation des bases conceptuelles de l'OE et de ses aspects développementaux, les auteurs exposent de façon détaillée les résultats empiriques du modèle dans différents domaines de la psychologie clinique et de la psychologie de la santé (troubles de la personnalité, troubles de la dépendance, troubles anxieux, phobies, troubles somatoformes ou burnout, satisfaction dans le couple, bien-être individuel). Enfin ils fournissent des pistes et conseils pour l'application pratique du modèle de l'OE en intervention psychologique et en psychothérapie. En annexe, le lecteur trouvera l'ensemble des instruments (questionnaires et instruments d'auto-observation), sur lesquels repose le modèle de l'OE et qui sont inédits à ce jour.

The TREAT-NMD Duchenne Muscular Dystrophy Registries: Conception, Design, and Utilization by Industry and Academia.

Duchenne muscular dystrophy (DMD) is an X-linked genetic disease, caused by the absence of the dystrophin protein. Although many novel therapies are under development for DMD, there is currently no cure and affected individuals are often confined to a wheelchair by their teens and die in their twenties/thirties. DMD is a rare disease (prevalence <5/10,000). Even the largest countries do not have enough affected patients to rigorously assess novel therapies, unravel genetic complexities, and determine patient outcomes. TREAT-NMD is a worldwide network for neuromuscular diseases that provides an infrastructure to support the delivery of promising new therapies for patients. The harmonized implementation of national and ultimately global patient registries has been central to the success of TREAT-NMD. For the DMD registries within TREAT-NMD, individual countries have chosen to collect patient information in the form of standardized patient registries to increase the overall patient population on which clinical outcomes and new technologies can be assessed. The registries comprise more than 13,500 patients from 31 different countries. Here, we describe how the TREAT-NMD national patient registries for DMD were established. We look at their continued growth and assess how successful they have been at fostering collaboration between academia, patient organizations, and industry.

Design and establishment of a biobank in a multicenter prospective cohort study of elderly patients with venous thromboembolism (SWITCO65+).

In the field of thrombosis and haemostasis, many preanalytical variables influence the results of coagulation assays and measures to limit potential results variations should be taken. To our knowledge, no paper describing the development and maintenance of a haemostasis biobank has been previously published. Our description of the biobank of the Swiss cohort of elderly patients with venous thromboembolism (SWITCO65+) is intended to facilitate the set-up of other biobanks in the field of thrombosis and haemostasis. SWITCO65+ is a multicentre cohort that prospectively enrolled consecutive patients aged ≥65 years with venous thromboembolism at nine Swiss hospitals from 09/2009 to 03/2012. Patients will be followed up until December 2013. The cohort includes a biobank with biological material from each participant taken at baseline and after 12 months of follow-up. Whole blood from all participants is assayed with a standard haematology panel, for which fresh samples are required. Two buffy coat vials, one PAXgene Blood RNA System tube and one EDTA-whole blood sample are also collected at baseline for RNA/DNA extraction. Blood samples are processed and vialed within 1 h of collection and transported in batches to a central laboratory where they are stored in ultra-low temperature archives. All analyses of the same type are performed in the same laboratory in batches. Using multiple core laboratories increased the speed of sample analyses and reduced storage time. After recruiting, processing and analyzing the blood of more than 1,000 patients, we determined that the adopted methods and technologies were fit-for-purpose and robust.

Efficacy of an adjunctive brief psychodynamic psychotherapy to usual inpatient treatment of depression: rationale and design of a randomized controlled trial.

BACKGROUND: A few recent studies have found indications of the effectiveness of inpatient psychotherapy for depression, usually of an extended duration. However, there is a lack of controlled studies in this area and to date no study of adequate quality on brief psychodynamic psychotherapy for depression during short inpatient stay exists. The present article describes the protocol of a study that will examine the relative efficacy, the cost-effectiveness and the cost-utility of adding an Inpatient Brief Psychodynamic Psychotherapy to pharmacotherapy and treatment-as-usual for inpatients with unipolar depression. METHODS/DESIGN: The study is a one-month randomized controlled trial with a two parallel group design and a 12-month naturalistic follow-up. A sample of 130 consecutive adult inpatients with unipolar depression and Montgomery-Asberg Depression Rating Scale score over 18 will be recruited. The study is carried out in the university hospital section for mood disorders in Lausanne, Switzerland. Patients are assessed upon admission, and at 1-, 3- and 12- month follow-ups. Inpatient therapy is a manualized brief intervention, combining the virtues of inpatient setting and of time-limited dynamic therapies (focal orientation, fixed duration, resource-oriented interventions). Treatment-as-usual represents the best level of practice for a minimal treatment condition usually proposed to inpatients. Final analyses will follow an intention-to-treat strategy. Depressive symptomatology is the primary outcome and secondary outcome includes measures of psychiatric symptomatology, psychosocial role functioning, and psychodynamic-emotional functioning. The mediating role of the therapeutic alliance is also examined. Allocation to treatment groups uses a stratified block randomization method with permuted block. To guarantee allocation concealment, randomization is done by an independent researcher. DISCUSSION: Despite the large number of studies on treatment of depression, there is a clear lack of controlled research in inpatient psychotherapy during the acute phase of a major depressive episode. Research on brief therapy is important to take into account current short lengths of stay in psychiatry. The current study has the potential to scientifically inform appropriate inpatient treatment. This study is the first to address the issue of the economic evaluation of inpatient psychotherapy. TRIAL REGISTRATION: Australian New Zealand Clinical Trial Registry (ACTRN12612000909820).